Cushing-Haugen KL - Search Results

1

Cigarette smoking and risk of epithelial ovarian cancer.

Rossing MA, Cushing-Haugen KL, Wicklund KG, Weiss NS. Rossing MA, et al. Cancer Causes Control. 2008 May;19(4):413-20. doi: 10.1007/s10552-007-9103-8. Epub 2007 Dec 15. Cancer Causes Control. 2008. PMID: 18080774

2

Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases.

Malone KE, Daling JR, Neal C, Suter NM, O'Brien C, Cushing-Haugen K, Jonasdottir TJ, Thompson JD, Ostrander EA. Malone KE, et al. Cancer. 2000 Mar 15;88(6):1393-402. doi: 10.1002/(sici)1097-0142(20000315)88:6<1393::aid-cncr17>3.0.co;2-p. Cancer. 2000. PMID: 10717622

3

Cimetidine use and risk of prostate and breast cancer.

Rossing MA, Scholes D, Cushing-Haugen KL, Voigt LF. Rossing MA, et al. Cancer Epidemiol Biomarkers Prev. 2000 Mar;9(3):319-23. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10750671

4

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.

Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, Daling JR. Li CI, et al. JAMA. 2003 Jun 25;289(24):3254-63. doi: 10.1001/jama.289.24.3254. JAMA. 2003. PMID: 12824206

5

Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.

Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR. Li CI, et al. Cancer. 2003 Oct 1;98(7):1504-13. doi: 10.1002/cncr.11663. Cancer. 2003. PMID: 14508839 Free article.

6

Body mass index, weight, and oral contraceptive failure risk.

Holt VL, Scholes D, Wicklund KG, Cushing-Haugen KL, Daling JR. Holt VL, et al. Obstet Gynecol. 2005 Jan;105(1):46-52. doi: 10.1097/01.AOG.0000149155.11912.52. Obstet Gynecol. 2005. PMID: 15625141

7

Risk of functional ovarian cyst: effects of smoking and marijuana use according to body mass index.

Holt VL, Cushing-Haugen KL, Daling JR. Holt VL, et al. Am J Epidemiol. 2005 Mar 15;161(6):520-5. doi: 10.1093/aje/kwi080. Am J Epidemiol. 2005. PMID: 15746468

8

Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy.

Chubak J, Doherty JA, Cushing-Haugen KL, Voigt LF, Saltzman BS, Hill DA, Beresford SA, Weiss NS. Chubak J, et al. Cancer Causes Control. 2007 Nov;18(9):1001-7. doi: 10.1007/s10552-007-9040-6. Epub 2007 Jul 25. Cancer Causes Control. 2007. PMID: 17653829

9

Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer.

Doherty JA, Cushing-Haugen KL, Saltzman BS, Voigt LF, Hill DA, Beresford SA, Chen C, Weiss NS. Doherty JA, et al. Am J Obstet Gynecol. 2007 Aug;197(2):139.e1-7. doi: 10.1016/j.ajog.2007.01.019. Am J Obstet Gynecol. 2007. PMID: 17689625

10

Menopausal hormone therapy and risk of epithelial ovarian cancer.

Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS. Rossing MA, et al. Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2548-56. doi: 10.1158/1055-9965.EPI-07-0550. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 18086757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters